BioSpace News Archive

Medivir to present at the Pareto Securities´ Healthcare conference

Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the Pareto Securities´ Healthcare conference on September 7, 2022.

September 1, 2022
·
1 min read
BioMidwest

BioLab Sciences Dermistat™ is Changing the Wound Care Market

DermistatTM, one of the latest wound healing innovations by BioLab Sciences, a regenerative biotechnology company, has emerged as the go-to wound healing option for wound care specialists and podiatrists throughout the country.

September 1, 2022
·
2 min read
Venus Medtech announces 2022 interim results: quality and efficiency improvement, profitability focus, rapid progress in global presence

On August 31, 2022, Venus Medtech Inc., a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced its interim results for the six months ended June 30, 2022.

September 1, 2022
·
5 min read
Business

NeuroMetrix Names Jonathan Breck Harmel as National Director of Sales for its Emerging Prescription Neurotherapeutics Business

NeuroMetrix, Inc. announced that it has appointed Jonathan “Breck” Harmel as National Director of Sales, Neuromodulation.

September 1, 2022
·
2 min read
Business

GeoVax Announces Addition to Its Board of Directors

GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced that it has appointed Nicole Lemerond, CFA, to its Board of Directors.

September 1, 2022
·
4 min read
Biotech Bay

AVÉLI™ RECEIVES EXTENDED FDA CLEARANCE FOR THE LONG-TERM REDUCTION OF CELLULITE IN THE BUTTOCKS AND THIGHS

Revelle Aesthetics, Inc. (Revelle) – a VC-backed Silicon Valley MedTech company – achieves an extended FDA clearance for its precision cellulite release device, Avéli™.

September 1, 2022
·
4 min read
Drug Development

Aston Sci. Receives IND Approval from FDA for Phase 2 Clinical Trial of Therapeutic Cancer Vaccine AST-301 in Patients with TNBC

Aston Sci. Inc., a clinical stage biopharmaceutical company specializing in clinical development of therapeutic cancer vaccines, announced that it obtained IND approval from the U.S. Food and Drug Administration (FDA) for Phase 2 clinical trial of its main product, AST-301 (HER2-ICD vaccine).

September 1, 2022
·
3 min read
Business

ICARE HEALTH SOLUTIONS ANNOUNCES STEPHEN KENDIG AS NEW CHIEF OPERATING OFFICER

iCare Health Solutions, a VSP Vision™ company, announced Stephen Kendig as its new Chief Operating Officer.

September 1, 2022
·
1 min read
Biotech Beach

Vanderbilt Completes Study Evaluating Advanced, Four-Dimensional Lung Imaging Software from 4DMedical

4DMedical, the leading developer of functional imaging software for respiratory illness, announced successful completion of a study by Vanderbilt University Medical Center of post-deployment veterans referred by the Nashville VA.

September 1, 2022
·
4 min read
BioMidwest

Insightec Announces Financing up to $200 Million to Fund Continued Growth

Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, announced that it signed a credit facility for up to $200 million with affiliates of existing shareholders Perceptive Advisors and Community Fund.

September 1, 2022
·
3 min read